BEAM

#1615
Beam Therapeutics Inc. - Common Stock
32.6 4 USD
-1.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
32.12
33.00
Range Annuel
15.35
36.44
Changement quotidien
-1.00%
Changement Mensuel
+10.61%
Evolution sur 6 mois
+31.72%
Changement Annuel
+102.11%
Clôture Précédente
32.9 7
Open
32.7 5
Low
32.1 2
High
33.0 0
Volume
217
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 3.36 B
  • Employee 511
  • Founded 2017
  • CEO John Evans
  • Website www.beamtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00KXC8646
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-34.22
ratio cours/chiffre d'affaires
19.62

Beam Therapeutics Inc. - Common Stock

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Nouvelles